Ceftobiprole

WikiDoc Resources for Ceftobiprole
Articles
Most recent articles on Ceftobiprole Most cited articles on Ceftobiprole Review articles on Ceftobiprole Articles on Ceftobiprole in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ceftobiprole Images of Ceftobiprole Photos of Ceftobiprole Podcasts & MP3s on Ceftobiprole Videos on Ceftobiprole
Evidence Based Medicine
Cochrane Collaboration on Ceftobiprole Bandolier on Ceftobiprole TRIP on Ceftobiprole
Clinical Trials
Ongoing Trials on Ceftobiprole at Clinical Trials.gov Trial results on Ceftobiprole Clinical Trials on Ceftobiprole at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ceftobiprole NICE Guidance on Ceftobiprole NHS PRODIGY Guidance FDA on Ceftobiprole CDC on Ceftobiprole
Books
Books on Ceftobiprole
News
Ceftobiprole in the news Be alerted to news on Ceftobiprole News trends on Ceftobiprole
Commentary
Blogs on Ceftobiprole
Definitions
Definitions of Ceftobiprole
Patient Resources / Community
Patient resources on Ceftobiprole Discussion groups on Ceftobiprole Patient Handouts on Ceftobiprole Directions to Hospitals Treating Ceftobiprole Risk calculators and risk factors for Ceftobiprole
Healthcare Provider Resources
Symptoms of Ceftobiprole Causes & Risk Factors for Ceftobiprole Diagnostic studies for Ceftobiprole Treatment of Ceftobiprole
Continuing Medical Education (CME)
CME Programs on Ceftobiprole
International
Ceftobiprole en Espanol Ceftobiprole en Francais
Business
Ceftobiprole in the Marketplace Patents on Ceftobiprole
Experimental / Informatics
List of terms related to Ceftobiprole

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Ceftobiprole is an experimental cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus. It was discovered by Basilea Pharmaceutica and is being developed by Johnson & Johnson Pharmaceutical Research and Development.